![](https://endpts.com/wp-content/uploads/2021/09/Sam-Waksal-Getty-scaled.jpg)
Sam Waksal (Robin Marchant/Getty Images)
Sam Waksal's ROCK2 biotech Graviton hauls in $35M boost from Enavate
Investors are pouring more money into a biotech created by industry veteran Sam Waksal, founder of ImClone Systems, Kadmon, MeiraGTx and Équilibre Biopharmaceuticals, and who …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.